投资者的目光正聚焦于SpaceX那庞大的星舰火箭。星链卫星互联网服务，才是其主要的赚钱机器。然而，就在周四，SpaceX最新的一款航天器迎来了首位客户。太空与国防公司Redwire宣布，已达成协议，将把其轨道制药技术，通过SpaceX的“星陨”航天器，送往近地轨道——而这款飞行器尚未进行过任何飞行任务。SpaceX对“星陨”一直语焉不详，但已向联邦监管机构提交了相关计划，描述其为一种圆柱形太空舱，高仅2.5英尺，直径却超过10英尺。Redwire计划在一艘“星陨”飞行器上，装填其“太空制药实验室”设备。这些设备让研究人员得以在微重力环境中进行药物实验，旨在合成出全新的化合物。作为此次任务的一部分，“星陨”将携带这批制药货物重返地球大气层，随后送回地面进行分析。Redwire表示，其“星陨”飞行任务预计在2028年启程。受此消息提振，Redwire股价周四飙升逾13%，收于12.16美元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.